Closer relationships with clinical trial partners are key to ensuring long-term trial success with German pharma giant Bayer, says the company’s Latin America external manufacturing head, Luiz ...

Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is ...

“Failure to recruit patients for trials leads to delays in drug development, which are bad both for sponsors and patients,” Sagar Vaidya, Chief Medical Officer of Cerevance during a presentation at ...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED Inc. (www.tiximed.com), a clinical-stage pharmaceutical company based on the breakthrough discovery that TXNIP plays an important role in the development and ...

- New funding will drive expansion, including in international markets; London office to open this Fall in United Kingdom - Expansion underpinned by new senior hires, including Chief Financial Officer ...

Biometric CRO Quanticate will work with PhaseV, a machine learning company developing software for clinical trials, to launch a new service that aims to help sponsors design and optimize adaptive ...

To be accepted into a clinical trial, all potential participants must meet the "eligibility criteria" by having similar ...

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...

April 2 (UPI) --Heart disease experts are hailing the results of a clinical trial that showed a strongly positive performance by Eli Lilly's drug lepodisiran, which inhibits the body's production of ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...